On Thursday, H.C. Wainwright reaffirmed its Buy rating and maintained a $25.00 stock price target for Calumet Specialty Products Partners (NASDAQ:CLMT), following a significant development regarding the company's renewable fuels project.
Calumet Specialty Products Partners recently announced that its unrestricted subsidiary, Montana Renewables LLC (MRL), has secured a conditional commitment from the U.S. Department of Energy's (DoE) Loan Programs Office (LPO) for a loan guarantee of up to $1.44 billion.
The funding is earmarked for the construction and expansion of MRL's renewable fuels facility, which is poised to become one of the world's leading producers of Sustainable Aviation Fuel (SAF). The proposed expansion will enable MRL to achieve a production capacity of 300 million gallons of SAF and a combined total of 330 million gallons of SAF and renewable diesel (RD).
MRL has outlined a series of projects to enhance its production capabilities. These include the addition of a second renewable fuels reactor to reach half of the 300 million gallon SAF production target by 2026, de-bottlenecking of current renewable fuels and feedstock pretreatment units, and the installation of SAF blending and logistics assets.
The expansion plan also encompasses increased renewable hydrogen production, the addition of cogeneration for renewable electricity and steam, on-site water treatment and recycling, as well as other site improvements.
The analyst from H.C. Wainwright reiterated the firm's positive stance on Calumet Specialty Products Partners, citing the recent development as a significant step forward for the company's renewable fuels initiative. The reiteration of the Buy rating and the $25 price target reflects the firm's confidence in the company's prospects following the DoE's loan guarantee commitment.
In other recent news, Calumet Inc. has been making significant strides in its financial and operational activities. The company secured a Department of Energy (DoE) loan to fund the expansion of its Sustainable Aviation Fuel (SAF) production, a move that led TD Cowen to raise its price target on Calumet shares. Calumet's SAF production is expected to boost the company's EBITDA outlook, a factor that justified the higher price target from TD Cowen.
The company has also received conditional loan guarantee commitments from the U.S. Department of Energy totaling nearly $3 billion. This funding will support the expansion of their Montana-based facility, increasing its production capacity to approximately 315 million gallons of biofuels annually. The majority of this production will be SAF, aligning with the broader goal of supplying all U.S. aviation fuel needs with SAF by 2050.
In addition to these developments, Calumet has entered into a $150 million sale and leaseback transaction with Stonebriar Commercial Finance for its subsidiary, Calumet Montana Refining. This move is part of Calumet's ongoing efforts to reduce its debt, as demonstrated by the repayment of $50 million of its 2025 notes.
Furthermore, analysts from TD Cowen and H.C. Wainwright have maintained a Buy rating on Calumet's shares. This follows the company's strong Q1 EBITDA of $21.6 million and the recent conversion to a corporation. These are the recent developments within the company.
InvestingPro Insights
Calumet Specialty Products Partners' recent developments in renewable fuels align with its strong market performance. According to InvestingPro data, the company's stock has shown impressive returns, with a 40.22% price increase over the last three months and a 45.04% gain over the past six months. This upward trend has brought the stock price to 99.77% of its 52-week high, reflecting investor optimism about the company's strategic moves.
Despite these positive indicators, InvestingPro Tips highlight some potential concerns. The company operates with a significant debt burden, which could be a factor to watch as it embarks on its expansion plans. Moreover, Calumet's gross profit margins are reported as weak, with the latest data showing a gross profit margin of 12.81% for the last twelve months as of Q2 2024.
For investors seeking a more comprehensive analysis, InvestingPro offers 15 additional tips for Calumet Specialty Products Partners, providing a deeper understanding of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.